1. Introduction {#sec0005}
===============

New asymmetrically biocatalytic methods continue to be developed for the production of enantiomerically pure chiral amino acids which constitute a significant fraction of the chiral building blocks that are required as intermediates for a range of target molecules, including pharmaceuticals and agrochemicals [@bib0155], [@bib0175]. Traditional biocatalytic methods for the production of chiral chemicals have relied on hydrolytic enzymes, such as lipase [@bib0025], acylases [@bib0075], [@bib0140] and hydantoinases [@bib0095], and ammonia lyase and aminomutase [@bib0045], [@bib0065], [@bib0115], [@bib0155]. Among these enzymes, the phenylalanine ammonia lyase (PAL) (EC 4.3.1.5) and phenylalanine aminomutase (PAM) have been used for the synthesis of a broad range of arylalanines [@bib0045], [@bib0105], [@bib0145], [@bib0155].

The industrial-scale production of PAL mainly utilizes the strains of the *Rhodotorula* genus [@bib0060], [@bib0160]. We previously screened strains from soil and identified a *Rhodotorula glutinis* strain with higher PAL activity, which was denoted JN-1 (CCTCC M2011490). The full-length gene of the phenylalanine ammonia lyase (*Rg*PAL) from *R. glutinis* JN-1was isolated and successfully expressed in *E. coli* [@bib0190]. The *Rg*PAL is a member of the 4-methylene-imidazol-5-one (MIO)-dependent enzyme family, which includes PAL, histidine ammonia-lyase (HAL) [@bib0135], tyrosine ammonia-lyase (TAL) [@bib0100], and PAM and tyrosine aminomutases (TAM) [@bib0065], [@bib0070], [@bib0145]. The MIO is a highly electrophilic prosthetic group that is formed post-translationally from a highly conserved Ala--Ser--Gly motif ([Fig. 1](#fig0005){ref-type="fig"}), which attacks the substrate to facilitate the elimination of ammonia [@bib0120]. The *Rg*PAL is shown to region-and-stereo selectively catalyze [l]{.smallcaps}-phenylalanine to *trans*-cinnamic acid and can be used to resolve [dl]{.smallcaps}-phenylalanine to produce the [d]{.smallcaps}-phenylalanine. The solubility of the *trans*-cinnamic acid is low at acidic side (about 0.006 g/L in aqueous solution at 25 °C), and the [d]{.smallcaps}-phenylalanine could be easily separated from the reaction solution through pH controlling. Therefore, the asymmetric resolution of racemic [dl]{.smallcaps}-phenylalanine by PAL is an attractive route and exhibits commercial application prospects. However, the optimum pH of *Rg*PAL is 9 and the *Rg*PAL exhibits low catalytic efficiency at acidic side; the *trans*-cinnamic acid exhibits high solubility at pH 9 and the accumulated *trans*-cinnamic acid during the reaction inhibits the catalysis, which presents a significant barrier to *Rg*PAL application. Therefore, a mutant *Rg*PAL with a lower optimum pH is expected.Fig. 1Amino acid sequence alignment of *Rg*PAL with other PALs, HAL, and TAL.The sequences shown are from *Rhodotorula glutinis* (*Rg*PAL), *R. toruloides* (*Rt*PAL), *P. crispum* (*Pc*PAL), *Pseudomonas putida* (*Pp*HAL), and *Rhodobacter sphaeroides* (*Rs*TAL). The MIO prosthetic group, and His136, Gln137, Arg361, Tyr358, and Glu491 are indicated.

The optimum pH of enzymatic activity is often determined by the ionizable amino acids at active site that are involved in catalysis and substrate binding [@bib0150], [@bib0180]. The key issue is that which ionizable amino acids can be accurately picked out, and the catalytic mechanism and structure analysis can provide useful information in this aspect [@bib0185]. The *Rg*PAL acts through the Friedel--Crafts-type mechanism (Fig. S1) [@bib0005], [@bib0110], [@bib0125]. In the reaction, the MIO attack the phenyl ring of the substrate to form carbocation **1** which would stabilize intermediate **2** formed by removal of the substrate's C-3 hydrogen [@bib0005], [@bib0015]. Collapse of the system to product occurs with the elimination of NH~3~ and the release of *trans*-cinnamic acid from the MIO. Reservations on this mechanism center on the potentially large energy barrier that must be surpassed in forming the carbocation intermediate [@bib0015]. Therefore, negative charge around the phenyl ring might be involved in stabilizing the carbocation intermediate through electrostatic interaction and could facilitate the elimination of NH~3~.

In this work, we aim to shift the optimum pH of *Rg*PAL toward the acidic side. Based on analyses of catalytic mechanism and structure, the His136 and Gln137 residues of *Rg*PAL were found to form a hairpin motif to clamp the phenyl ring of substrate. The *Rg*PAL-Q137E mutant extended the optimum pH to the range of 7--9. The specific activity of *Rg*PAL-Q137E mutant was increased 1.8-fold at pH 7. The effective strategy for improving the catalytic activity and shifting the optimum pH is favorable to further applications of *Rg*PAL.

2. Materials and methods {#sec0010}
========================

2.1. Plasmids and strains {#sec0015}
-------------------------

The plasmids pMD18-T (Takara, Japan) and pET-28a (+) (Novagen, USA) were used for cloning and expression. The pET-28a-*pal* that encodes the *Rg*PAL gene from *R. glutinis* JN-1 (CCTCC M2011490) was constructed in our previous study [@bib0190]. The *E. coli* strains JM109 and BL21 (DE3) (Novagen, USA) were used as a host strains for plasmid amplification and enzyme expression, respectively.

2.2. Site-directed mutagenesis {#sec0020}
------------------------------

The mutants were constructed using site-directed mutagenesis. The PCR reaction was conducted using the PrimeSTAR HS DNA polymerase (Takara, Japan) and the pET-28a-*pal* plasmid as the template DNA. The primers are shown in Supplementary Table S1. The PCR product was digested by *Dpn*I (Takara, Japan) at 37 °C for 1 h. The PCR product was transformed into competent cells of *E. coli* JM109. After the sequence verified, the extracted plasmid was transformed into *E. coli* BL21 (DE3) for enzyme expression.

2.3. Expression and purification of *Rg*PAL and its mutants {#sec0025}
-----------------------------------------------------------

The wild type and mutant proteins were expressed with N-terminal His-tag using the pET-28a (+) vector. The cells were grown to an OD~600~ of 0.6, and the enzyme expression was induced using 0.4 mM IPTG. After the cells were shaken at 24 °C for 20 h, the cells were collected by centrifugation (5 min, 4 °C, 10,000 × *g*), washed twice with 50 mM sodium phosphate buffer (containing 10 mM imidazole, and 150 mM NaCl, pH 7.5) and sonificated on ice at 40% power. After centrifugation, the supernatant was stored at 4 °C. The enzymes were purified by His-tag-purification using an Akta-purifier (GE Healthcare). The proteins were loaded onto a 1 mL HisTrap FF crude column (GE Healthcare), and the column was then washed using the same buffer and 58.3% of the elution-buffer (containing 250 mM imidazole, 150 mM NaCl). After elution, the enzyme was desalted using a HiPrep 26/10 desalting column (GE Healthcare) equilibrated with buffer (50 mM Tris--HCl, pH 8.6). The purity of the sample was detected through SDS-PAGE, and the concentration of enzyme protein was measured by Bradford method [@bib0010].

2.4. Computer-aided modeling and docking {#sec0030}
----------------------------------------

The model of *Rg*PAL was created through the submission of the sequence to SWISS-MODEL (<http://swissmodel.expasy.org/>) using the *Rt*PAL (PDB ID: 1T6J) from *R. toruloides* with 75% identity as the template. The model was analyzed using the SWISS-MODEL server as described by Bartsch, Donnelly, and Rother [@bib0005], [@bib0020], [@bib0130]. Substrates were docked into the active site using Autodock (version 4), and the substrate binding was analyzed according to the method described by Wang [@bib0165] and Bartsch [@bib0005].

2.5. Circular dichroism (CD) {#sec0035}
----------------------------

The CD spectra were measured on MOS-450/AF-CD-STP-A (Bio-Logic, France) at a protein concentration of 0.1 mg/mL in 50 mM Tris/HCl buffer (pH 8.6) using a 1 cm path-length quartz cuvette. To minimize the signal baseline drift, the spectropolarimeter and xenon lamp were warmed up at least 30 min prior to each experiment. The enzyme data in the 190--240 nm bands were collected, and which the spectrum obtained for a buffer blank was subtracted from these data.

2.6. Activity assay of *Rg*PAL {#sec0040}
------------------------------

The assay to determine the kinetic parameters were performed using different concentrations of [l]{.smallcaps}-phenylalanine (1--20 mM) (Sigma--Aldrich, Germany). The reactions were initiated by the addition of an appropriate quantity of *Rg*PAL to each reaction system. The reaction was conducted at 40 °C and stopped by addition of 0.5 mL of methanol. The formation of *trans*-cinnamic acid was measured by HPLC (Hitachi, Japan) at 290 nm, the mobile phase contained 50% methanol. The obtained experimental dependences of the initial catalytic rates on the substrate concentrations were fitted to Michaelis--Menten equation through nonlinear regression analysis using Origin (7.5 versions). One enzyme activity unit was defined as the amount of enzyme that produced 1 μmol *trans*-cinnamic acid per minute at 40 °C.

The effects of the pH were determined at 40 °C using a series of buffers with various pH values (pH 5.0--7.0, 50 mM sodium acetate buffer; pH 7.0--9.0, 50 mM Tris--HCl buffer; pH 9.0--12.0, 50 mM sodium carbonate buffer).

2.7. The resolution of racemic [dl]{.smallcaps}-phenylalanine using *Rg*PAL and *Rg*PAL-Q137E {#sec0045}
---------------------------------------------------------------------------------------------

The chiral resolutions of [dl]{.smallcaps}-phenylalanine using *Rg*PAL and *Rg*PAL-Q137E were performed at pH 7 and pH 9, respectively. The experiments were carried out in 500 mL batch conical flasks with lid in a rotating shaker and contained 300 mL of [dl]{.smallcaps}-phenylalanine (100 mM) and 250 μg of pure enzyme at 40 °C. The conversion rate of [l]{.smallcaps}-phenylalanine and the *ee*~D~ value of [d]{.smallcaps}-phenylalanine were calculated by the following equations: $$\begin{matrix}
{\text{conversion\ rate} = \left\lbrack \frac{(L_{phe,in} - L_{phe,out})}{L_{phe,in}} \right\rbrack \times 100\%} \\
{{ee}_{D} = {\left\lbrack \frac{(D_{phe} - L_{phe,out})}{{(D}_{phe} + L_{phe,out})} \right\rbrack \times 100\%}} \\
\end{matrix};$$where the *ee*~D~ is the enantiomeric excess of [d]{.smallcaps}-phenylalanine; the L~phe,\ in~ is the initial concentration of [l]{.smallcaps}-phenylalanine; the L~phe,out~ is the residual concentration of [l]{.smallcaps}-phenylalanine after resolution; the D~phe~ is the concentration of [d]{.smallcaps}-phenylalanine. The [d]{.smallcaps}-phenylalanine and [l]{.smallcaps}-phenylalanine are detected through HPLC (Hitachi, Japan) at 205 nm according to the method described by Fukuhara [@bib0035]. The mobile phase contained 20% methanol and a complex of optically active L-Pro-Cu(II) (1.5 mM L-Pro and 0.75 mM CuSO~4~).

2.8. Data analysis {#sec0050}
------------------

The "mutational effect" was determined by dividing the *k*~cat~ value of the mutant enzyme by that of the wild type, and the free energy (ΔΔG^‡^) was calculated from the following equation: ΔΔG^‡^ = −RTln (mutational effect) as described by Olucha (2011, 2012) [@bib0085], [@bib0090].

3. Results {#sec0055}
==========

3.1. Selection of mutation sites based on homology modeling of the *Rg*PAL structure {#sec0060}
------------------------------------------------------------------------------------

The active site typically contains ionizable groups (Arg, Lys, His, Glu, and Asp) that are involved in substrate binding and catalysis and that determine the pH activity profile of an enzyme [@bib0150]. To successfully select those residues in the active site, a theoretical model of *Rg*PAL was constructed through homology modeling using *Rt*PAL (PDB ID: 1T6J) as the template. As shown in [Fig. 2](#fig0010){ref-type="fig"}, all of the residues that were the superimposed with *Rt*PAL showed an RMSD of 0.224 Å ([Fig. 2A](#fig0010){ref-type="fig"}), and the Ramachandran plot suggests that 94.9%, 3.2%, and 1.9% of the residues in derived model are in acceptable region, marginal region and disallowed region, respectively ([Fig. 2B](#fig0010){ref-type="fig"}), These finding indicated that the model is reasonable and could be used in further molecular docking simulation. Using the AutoDock global--local evolutionary algorithm, we searched for those sites with the lowest free energy of binding between the ligand and the enzyme. As shown in [Fig. 3](#fig0015){ref-type="fig"}, the active site cavity of *Rg*PAL was bisected into two regions ([Fig. 3A](#fig0015){ref-type="fig"}): one binds the amide group adjacent to the aromatic ring and the other binds the carboxyl group of the substrate. The phenyl ring of the substrate is roughly orthogonal to the plane of the MIO, and the methylidene of the MIO points to C2 of the aromatic ring ([Fig. 3](#fig0015){ref-type="fig"}A and B). In the carboxyl group binding pocket, the Arg361 residue is 3.2 Å from the carboxyl group of the substrate, and this residue might play a role in the binding of the carboxylate moiety of the substrate through a salt bridge. The Tyr358 residue is 2.7 Å from the β-H of substrate, which is close enough to act as the β-H abstracted base ([Fig. 3C](#fig0015){ref-type="fig"}). The Glu491 residue is the closet residue to the amino group of the substrate (2.8 Å, [Fig. 3C](#fig0015){ref-type="fig"}) and might accept the amino group of substrate as the enzyme base, which is consistent with the results reported by Bartsch [@bib0005]*.* The Tyr358, Arg361 and Glu491 are highly conserved in PAL ([Fig. 1](#fig0005){ref-type="fig"}). In the aromatic ring binding pocket, the His136 residue points to the phenyl ring of the substrate. The imidzaole group of His136 is parallel to the phenyl ring and might generate a π--π interaction. Moreover, the imidazole of His136 and the adjacent amide group of Gln137 which points to the phenyl ring within a distance of 4.5 Å, form a hairpin motif to clamp the phenyl ring ([Fig. 3](#fig0015){ref-type="fig"}B and C).Fig. 2Comparative modeling of *Rg*PAL and *Rt*PAL. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)(A) Superimposed monomer structures of *Rg*PAL and *Rt*PAL. The model of *Rg*PAL (red) was constructed using SWISS-MODEL and was superimposed with that of *Rt*PAL (yellow); (B) Ramachandran plot of *Rg*PAL. The red, yellow, pale-yellow, and grey white areas represent highly reliable, acceptable, marginal, and disallowed regions, respectively.Fig. 3Structural analysis and molecular docking of *Rg*PAL. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)(A) Solvent accessible surface of *Rg*PAL in the active site that binds to the substrate. The front part of the *Rg*PAL tetramer was removed to reveal the internal cavity in the vicinity of the MIO cofactor. The position of a substrate molecule bound to *Rg*PAL is shown in yellow. MIO is labeled (violet). (B) Two regions adjacent to the aromatic ring and the carboxyl group of the substrate in active site. The binding site of the carboxylic acid and the amine group of the substrate are indicated in yellow, and the binding site for the aromatic ring is shown in blue. (C) The relative positions of the residues in the active site. The distances from the substrate to His136, Gln137, Arg361, Tyr358, Glu491, and MIO in the active site are shown. The oxygen, nitrogen, and carbon atoms are shown in red, blue, and gray, respectively.

3.2. Effects of mutations at 136 and 137 sites on enzymatic activity {#sec0065}
--------------------------------------------------------------------

To verify the function of the hairpin, the His136, Gln137 were deleted (*Rg*PAL-Δ136H, *Rg*PAL-Δ137Q) and mutated to negative (*Rg*PAL-H136E, *Rg*PAL-Q137E) and positive charges (*Rg*PAL-H136K, *Rg*PAL-Q137K) as well as uncharged amino acids (*Rg*PAL-H136F, *Rg*PAL-Q137L), respectively. The mutant and wild type *Rg*PAL proteins appeared a single band of about 75 kDa on SDS-PAGE ([Fig. 4](#fig0020){ref-type="fig"}). The activities of *Rg*PAL-Δ136H and *Rg*PAL-Δ137Q were not detected (data not shown), suggesting that the residues at the two sites were essential for catalysis. The *Rg*PAL-H136K, *Rg*PAL-Q137K and *Rg*PAL-H136E lost the enzymatic activity (data not shown), and the *Rg*PAL-H136F, *Rg*PAL-Q137L sharply decreased the activity ([Fig. 5](#fig0025){ref-type="fig"}). Compared with those mutants, the activity of *Rg*PAL-Q137E decreased slightly ([Fig. 5](#fig0025){ref-type="fig"}). These findings are consistent with the Friedel--crafts-type mechanism; the positively charged or uncharged amino acids at active site were disadvantageous to the electrophilic attack on the aromatic ring of the substrate by the MIO.Fig. 4SDS-PAGE analysis of the purified wild-type and mutant proteins.Lanes: M, molecular marker; 1, wild-type *Rg*PAL; 2, *Rg*PAL-H136F; 3, *Rg*PAL-H136E; 4, *Rg*PAL-H136K; 5, *Rg*PAL-Δ136H; 6, *Rg*PAL-Q137E; 7, *Rg*PAL-Q137L; 8, *Rg*PAL-Q137K; 9, *Rt*PAL-Δ137Q, (Δ) indicated that the residue was deleted.Fig. 5Effects of mutation at 136 and 137 sites on the enzymatic activity.The reaction was conducted for 30 min at pH 9 and 40 °C, the activity of *Rg*PAL-H136E, *Rg*PAL-H136 K, *Rg*PAL-Δ136H, *Rg*PAL-Q137K, and *Rt*PAL-Δ137Q were not detected (data not shown).

3.3. Effects of pH on the activity of *Rg*PAL and *Rg*PAL-Q137E {#sec0070}
---------------------------------------------------------------

The effects of pH on the catalysis of *Rg*PAL-Q137E were further studied because the mutation at 136 and 137 sites decreased the activity except for *Rg*PAL-Q137E. The activity was determined over the pH range from 7--10 using a buffer system to maintain a constant ionic strength. Interestingly, the optimal pH of *Rg*PAL-Q137E was extended to 7--9, the activity of *Rg*PAL-Q137E at pH 7 (2.7 U/mg) is 1.8-fold higher than that of the wild type (1.5 U/mg) ([Fig. 6](#fig0030){ref-type="fig"}). The CD spectrum of the mutant was similar to that of the wild type ([Fig. 7](#fig0035){ref-type="fig"}) indicating that this mutant did not change the secondary structure of *Rg*PAL. These findings suggested that the pH range extension of *Rg*PAL-Q137E might results from the negative charge of Glu137, but not the secondary structure change.Fig. 6Effects of pH on the enzymatic activities of *Rg*PAL and *Rg*PAL-Q137E.The activity was determined over the pH range from 7--10 using a buffer system maintaining a constant ionic strength (pH 5.0--7.0, 50 mM sodium acetate buffer; pH 7.0--9.0, 50 mM Tris--HCl buffer; pH 9.0--12.0, 50 mM sodium carbonate buffer). (Δ) *Rg*PAL-Q137E; (□) *Rg*PAL.Fig. 7The conformation change of the mutants was checked with circular dichroism (CD).The CD spectra were measured at a protein concentration of 0.1 mg/mL in 50 mM Tris/HCl buffer (pH 8.6). solid line: *Rg*PAL; dotted line: *Rg*PAL-Q137E.

3.4. Asymmetric resolution of racemic [dl]{.smallcaps}-phenylalanine {#sec0075}
--------------------------------------------------------------------

The [dl]{.smallcaps}-phenylalanine was resolved using *Rg*PAL and *Rg*PAL-Q137E at pH 7 and pH 9, respectively. As shown in [Fig. 8](#fig0040){ref-type="fig"}, under the condition of pH 9, about 65% of [l]{.smallcaps}-phenylalanine was converted in both reactions after 16 h, and the conversion rates hardly increased after 16 h and the ultimate conversion rate and *ee*~D~ value were 72% and 58%, respectively. This may be due to the inhibition of the accumulated *trans*-cinnamic acid. On the other hand, when the reaction was carried out at pH 7, the precipitation of *trans*-cinnamic acid was observed, and the inhibition effect was obviously relieved. The conversion rate and *ee*~D~ value using *Rg*PAL-Q137E at pH 7 achieved 93% and 86% within 26 h, respectively, while the *Rg*PAL needed more than 45 h to achieve the same conversion rate at pH 7. These findings indicated that *Rg*PAL-Q137E was benefit for chiral resolution of [dl]{.smallcaps}-phenylalanine.Fig. 8The resolution process of [dl]{.smallcaps}-phe using *Rg*PAL and *Rg*PAL-Q137E.The resolution of [dl]{.smallcaps}-phenylalanine using *Rg*PAL and *Rg*PAL-Q137E were performed at pH 7 and pH 9, respectively.

4. Discussion {#sec0080}
=============

The His136 and Gln137 of *Rg*PAL seemed to form a hairpin motif to clamp the phenyl ring ([Fig. 3](#fig0015){ref-type="fig"}). The imidazole of His and the amide group of Gln in the hairpin motif contain lone pair electrons, which might increase the electron density of the phenyl ring of the substrate. According to Friedel--Crafts-type mechanism, the phenyl ring of the substrate with higher electron density is vulnerable to the attack by the MIO [@bib0015], [@bib0110]. Although the His and Phe present a similar structure, and both of His136 and F136 are likely to form π--π interaction with the phenyl ring of substrate ([Fig. 3B](#fig0015){ref-type="fig"}), the imidazole of His which contains richer electron rather than the phenyl ring of Phe at pH 9, is accessible to enhance the electron density of the phenyl ring of the substrate [@bib0005]. Therefore, the activity of *Rg*PAL-H136F was lower than that of *Rg*PAL at pH 9. Moreover, the amino acid at 136 site (His or Phe, [Fig. 1](#fig0005){ref-type="fig"}) is involved in recognizing the substrate [@bib0080], [@bib0170], the other mutations at this site would affect substrate binding. As a result, *Rg*PAL-H136E and *Rg*PAL-H136K lost the activity.

The Gln137 is only conserved in *Rg*PAL and *Rt*PAL but not in other PALs, HAL and TAL ([Fig. 1](#fig0005){ref-type="fig"}). The mutations at this site decreased or lost the activity except the *Rg*PAL-Q137E. The *Rg*PAL-Q137E mutant had an extended optimum pH 7--9 with the activity of about 1.8-fold higher than that of the wild type at pH 7 ([Fig. 6](#fig0030){ref-type="fig"}). The optimum pH of an enzyme depends on the ionizable amino acids at active site which are involved in catalysis [@bib0050], [@bib0055] or stabilization of transition state by electrostatic interaction [@bib0085], [@bib0090] and enzyme substrate binding [@bib0030]. The Glu137 might be involved in the stabilization of transition state by electrostatic interaction. According to the Friedel--Crafts-type mechanism, the carbocation intermediate is large energy barrier which must be surpassed [@bib0015]. The improvements of *Rg*PAL-Q137E at pH 7 may be due to the negative charge of Glu137 which facilitates stabilization of carbocation intermediate to reduce the energy barrier through electrostatic interaction. The *k*~cat~ value provides an assessment of the specificity and is directly related to the free energy of activation of the transition state [@bib0040], [@bib0085], [@bib0090]. Therefore, the calculation of mutational effects using *k*~cat~ provides insights on the contribution of electrostatics. As shown in [Table 1](#tbl0005){ref-type="table"}, the *k*~cat~ mutational effect was 0.56 at pH 7, which represents a ΔΔG^‡^ of 1.56 kcal/mol, and the *k*~cat~ mutational effect was found to be 0.93 at pH 9, which represents a ΔΔG^‡^ of 0.19 kcal/mol. Therefore, a negative charge at position 137contributes 1.32 kcal/mol (1.56 kcal/mol − 0.19 kcal/mol) of net free energy toward the electrostatic stabilization of the transition state. In addition, the negative charge of Glu137 is also likely to counteract the adverse effects of the positive charge of His136, which favors a protonated state at pH 7. The *p*K~a~ value of the imidazole group of His is approximately 5--7, and the His136 tends to exhibit the protonated state with a positive charge at pH 7, which is disadvantageous to the electrophilic attack MIO on the aromatic ring of the substrate by the MIO.Table 1Contribution of the negative charge at 137 site to activity.pHEnzyme*k*~cat~ (s^−1^) × 10^3^Mutational effect[a](#tblfn0005){ref-type="table-fn"}ΔΔG^‡^ (kJ M^−1^)7*Rg*PAL13.2 ± 0.7*Rg*PAL-Q137E23.6 ± 1.90.561.519*Rg*PAL23.1 ± 1.2*Rg*PAL-Q137E24.7 ± 1.40.930.191.32[b](#tblfn0010){ref-type="table-fn"}[^2][^3]

5. Conclusions {#sec0085}
==============

*Rg*PAL could be used to resolve [dl]{.smallcaps}-phenylalanine to produce optical pure [d]{.smallcaps}-phenylalanine, since the pH is one of the most important quality parameters for PAL catalytic reaction to resolve the [dl]{.smallcaps}-phenylalanine. In this study, the optimum pH of *Rg*PAL was shifted toward the acidic side through site-directed mutagenesis based on the analysis of catalytic mechanism and structure. The *Rg*PAL-Q137E mutant exhibited a wide pH range from 7 to 9. When this mutant was used to resolve the [dl]{.smallcaps}-phenylalanine, the conversion rate and *ee*~D~ value increased by 29% and 48%, and the ultimate conversion rate and *ee*~D~ value achieved 93% and 86%, respectively. However, the *ee*~D~ value and conversion rate using *Rg*PAL-Q137E need to be further improved, such research is currently carrying out in our lab. This work provides an effective strategy to shift the optimum pH for the enzyme application.
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